Back to search
FDAFDA · Food and drugs·Recall number D-0352-2019

Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31

Published January 16, 2019 · Recall initiated: January 2, 2019

Summary

FDA records drug Class II recall D-0352-2019, published January 16, 2019 and initiated January 2, 2019. Recalling firm: Heritage Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 5,060 units; Lot: Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Heritage Pharmaceuticals, Inc.
Distributor
Nationwide
Lot
Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31 recalled?

Yes. FDA published recall D-0352-2019 on January 16, 2019. Reported hazard: Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle

What should I do if I have this product?

Voluntary: Firm initiated · Letter